Posted in

LNN

Dr. Matthew Farrer Awarded Tom Isaacs Award

In memory of former co-founder and President of Cure Parkinson’s Tom Isaacs, who died in May 2017 aged 49, Cure Parkinson’s and Van Andel Institute jointly present this annual award to a researcher who has shown the greatest impact on the lives of people living with Parkinson’s and/or has involved…

RAB32 Ser71Arg in autosomal dominant Parkinson’s disease: linkage, association, and functional analyses

Congratulations to Drs. Jordan Follett and Matthew J Farrer on the publication of their research article “RAB32 Ser71Arg in autosomal dominant Parkinson’s disease: linkage, association, and functional analyses,” which appears in the June 2024 issue of The Lancet, Neurology. Summary Background Parkinson’s disease is a progressive neurodegenerative disorder with multifactorial causes, among which…

Newly discovered genetic variant clarifies why Parkinson’s develops

Mutation both causes the condition and could show how to halt it By Matthew Farrer June 8, 2024 Parkinson’s disease is a neurodegenerative movement disorder that progresses relentlessly. It gradually impairs a person’s ability to function until they ultimately become immobile and often develop dementia. In the U.S. alone, over a million…